Reckitt Benckiser Group PLC (LSE:RKT) - Share price

Stock Report

Reckitt Benckiser Group PLC RKT

Last Price

Day Change

As of 24/06/2022
17:51:45 BST | GBX
Minimum 15 Minutes Delay.

Last Close6,172.00p
Day Range6,176.00 - 6,260.00
Mkt Cap44.68Bil
52-Wk Range4,905.16 - 6,604.00
Yield %2.80

Share Price

Total Returns 24/06/2022

 Chg (%)  
More ...
Reckitt Benckiser Group PLC0.26 
FTSE 100 TR GBP-3.43
More ...
Income Statement
Operating Profit3,162.003,145.002,714.00
Net Profit-2,772.001,153.00-52.00
Reported EPS-393.00159.30-8.80
Balance Sheet
Current Assets5,033.005,314.004,862.00
Non Current Assets27,106.0025,978.0021,941.00
Total Assets32,139.0031,292.0026,946.00
Current Liabilities8,931.006,938.008,088.00
Total Liabilities22,732.0022,133.0019,493.00
Total Equity9,407.009,159.007,453.00
Cash Flow
Operating Cash Flow2,058.004,280.002,612.00
Net Change in Cash139.00149.00-350.00

Regulatory News

DateAuthor Headline
31/05/2022James Gard Top FTSE Dividend Paying Stocks
UPDATED for May 2022: A flurry of corporate updates in recent weeks have featured a number of dividend increases
11/07/2019James Gard Reckitt Shares Rise After Suboxone Settlement
Consumer giant settles with US regulators over the marketing of an opioid addiction drug Suboxone by former subsidiary Invidior
21/01/2019Emma Wall 5 Quality UK Stocks Going Cheap
A sustainable competitive advantage can protect a company’s revenues and profits. We outline five stocks with an advantage not priced in by the market
Director Dealings
More ...
09/06/2022DMr. Laxman Narasimhan6,158.4739824,511.00
15/09/2021DMr. Laxman Narasimhan5,916.9938722,899.00
03/08/2021PurchaseMs. S. Sara Mathew78.6524319,112.00
03/08/2021PurchaseDr. Pamela Josephine Kirby5,691.941,00056,919.00

Company Profile

Reckitt Benckiser was formed in 1999 through the merger of the British firm Reckitt & Colman and Dutch-based Benckiser. Recently rebranded under the corporate name Reckitt, it sells a portfolio that includes a variety of household and consumer health brands, such as Lysol, Finish, Durex, and Mucinex, many of which hold the number-one or -two positions in their categories globally. Reckitt has repositioned its portfolio and has entered the infant formula market through the acquisition of Mead Johnson in 2017, expanded its consumer health presence by acquiring Schiff Nutrition, K-Y, and Biofreeze, and has exited the food industry. The firm operates in 60 countries and sells products in more than 200, generating around 35% of sales from emerging markets.


Household & Personal Products


FTSE 100 , FTSE 350 , FTSE All Share , FTSE Eurotop 100 , FTSE Eurotop 300

Next Event 27/07/2022

Half-Yearly Results
More ...
PER (E)0.00
Div Yld (E)2.84
PEG (E)2.81
Op Mrgn0.21
EPS Grwth2.63
More ...
Record Date06/08/2129/04/22
More ...
Non-Executive DirectorMr. Andrew Robert John Bonfield
Non-Executive Director, ChairmanMr. Christopher Alan Sinclair
Non-Executive DirectorMr. Olivier Bohuon
Non-Executive Director, Senior Independent DirectorMr. Nicandro Durante
Non-Executive DirectorMs. S. Sara Mathew
Non-Executive DirectorDr. Pamela Josephine Kirby
Non-Executive DirectorMs. Margherita Della Valle
Executive Director, Chief Financial OfficerMr. Jeffrey Carr
Non-Executive DirectorMrs. Mary Elaine Harris
Non-Executive DirectorMs. Elane B. Stock
Non-Executive DirectorDr. Mehmood Khan
Executive Director, Chief Executive OfficerMr. Laxman Narasimhan
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2022 Morningstar. All rights reserved.